Health In Tech Q3 Loss Widens to $7.1M as Revenue Slips

Health In Tech, Inc. (Nasdaq: HIT) reported a third-quarter 2026 net loss of $7.1 million, or $(0.11) per diluted share, as revenue fell to $6.6 million from $8.5 million a year earlier, the company announced on November 12, 2026. The quarter included a $5.3 million provision for credit losses. Nine-month revenue was $23.4 million against $25.8 million in the prior-year period, while contracted revenue for the first nine months reached $32.7 million.

Context — Why the InsurTech Platform Is Under Pressure Now

Health In Tech's own comparison shows the swing clearly: a $0.5 million profit in Q3 2025 became a $7.1 million loss in Q3 2026, a $7.6 million reversal. For the nine-month stretch, $1.6 million of net income turned into an $11.2 million net loss, a $12.8 million move. The company attributed the deterioration partly to the $6.1 million nine-month credit-loss provision, a charge with no comparable line in the prior-year figures it disclosed.

The revenue decline also reflects a carrier transition. Health In Tech said the move to a new carrier temporarily extended underwriting and onboarding timelines, delaying the start of certain new policies. That pushed anticipated revenue from those opportunities into 2027 rather than eliminating them, according to the company.

Distribution growth continued even as revenue fell. The company counted 984 distribution partners — brokers, third-party administrators and agencies — at September 30, 2026, up 15.9% year over year. That widening base has not yet converted into recognized revenue at the pace the company had targeted.

A leadership change adds a strategic layer. Sanjay Shrestha became CEO effective October 20, 2026, with founder Tim Johnson moving to Executive Chairman. Shrestha said his immediate priority is improving quote-to-bind conversion and translating marketplace activity into placed policies and recognized revenue.

Data — What the Numbers Show

The gap between contracted revenue and GAAP revenue is the central figure. Of the $32.7 million in contracted revenue for the first nine months, $24.4 million was recognized as GAAP revenue before the enrollment adjustment and refund liability. The company expects $6.1 million more in the fourth quarter of 2026 and $2.2 million in 2027.

Pipeline revenue stood at $156.4 million as of October 30, 2026, of which $2.6 million was contracted after quarter end. The remaining $153.8 million sits in quoting or binding status, with an expected conversion rate of 3% to 7% — a range that, at the midpoint, implies roughly $7.7 million of eventual revenue.

Metric	Q3 2026	Q3 2025
Revenue	$6.6M	$8.5M
Net income (loss)	$(7.1)M	$0.5M
Diluted EPS	$(0.11)	$0.01

Platform Placed Plan Value was $91.8 million as of September 30, 2026, a measure of total economic value flowing through the platform rather than company revenue. Cash stood at $10.1 million. Adjusted EBITDA was $(3.9) million for the quarter and $(6.6) million for the nine months, which the company attributed to continued investment in distribution, technology and product development.

Analysis — What It Means for the InsurTech Sector

The cash position is the number that frames the risk. With $10.1 million on hand at September 30 and a $3.9 million quarterly Adjusted EBITDA burn, the company is operating with limited runway relative to its spending pace. That math sharpens the importance of the $6.1 million in contracted revenue the company expects to recognize in Q4 2026.

The pipeline conversion rate is the counter-argument worth weighing. A 3% to 7% expected conversion on $153.8 million is a wide band, and the low end would imply only about $4.6 million of eventual revenue. The company has not disclosed historical conversion rates, so investors cannot yet judge whether the range is conservative or optimistic.

Sector exposure runs through stop-loss insurance and the self-funded health plan market. Health In Tech's platform connects brokers, TPAs, managing general underwriters and carriers, so its revenue trajectory is a read on how quickly small and mid-sized employers are adopting self-funded arrangements. Rival InsurTech platforms and legacy stop-loss carriers compete for the same broker relationships, making the 984-partner count a competitive datapoint.

The $5.3 million credit-loss provision is the acknowledged limitation here. The company did not break out which counterparties or policy cohorts drove the charge, so the durability of that provision cannot be assessed from the disclosed figures. A repeat charge in Q4 would pressure the cash balance further.

Positioning is likely defensive into year-end. The revised outlook, the leadership transition and the credit provision are all recent developments, and the company said it will detail strategic priorities with full-year 2026 results.

Outlook — What to Watch Next

Three catalysts anchor the near term. First, the company's Q4 2026 report, when it has said it will provide a more detailed update on strategic priorities and full-year results. Second, the Three-Year Rate Stabilization Program, which has secured its first client and targets an initial launch by year-end 2026. Third, the HitRix marketplace launched in September 2026, an AI-powered broker platform for large-group self-funded stop-loss placement that the company expects to lift quoting efficiency and placement conversion.

The company revised its full-year 2026 revenue outlook to approximately $30 million, modestly below 2025 revenue. That figure is the level to track against the $6.1 million of contracted revenue expected in Q4. With the carrier transition described as substantially completed, policy onboarding speed becomes the variable that determines whether the 2027 revenue shift materializes.

Frequently Asked Questions

What does the $32.7 million contracted revenue figure actually mean for Health In Tech?

Contracted revenue is a period-based operating metric, not a backlog. It includes revenue from policies in force at any point during the reporting period, counting both amounts already recognized as GAAP revenue and remaining contractual revenue expected over each policy's term. Standard self-funded policies run 12 months; the Three-Year Rate Stabilization Program is designed for 36 months. It is presented before enrollment adjustments, so actual recognized revenue can differ.

Why did Health In Tech's net loss widen so sharply in Q3 2026?

Two factors drove the swing from $0.5 million of net income in Q3 2025 to a $7.1 million loss. The quarter carried a $5.3 million provision for credit losses, a charge absent from the prior-year comparison. Revenue also fell to $6.6 million from $8.5 million, which the company linked to a carrier transition that extended underwriting and onboarding timelines for certain new policies.

Is Health In Tech's cash position sufficient to fund operations?

The company reported $10.1 million in cash as of September 30, 2026, alongside Adjusted EBITDA of $(3.9) million for the quarter. It has not disclosed a runway estimate or committed financing. Management pointed to continued investment in distribution, technology and product development as the driver of the Adjusted EBITDA loss, and to the expected $6.1 million of Q4 contracted revenue recognition.

Bottom Line

Health In Tech's revenue fell and its loss widened, leaving pipeline conversion and Q4 contracted revenue recognition as the decisive tests.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.